Biotechnology Daily
more-
Business is booming for dialysis giant Fresenius. It took a $137M bailout anyway
As the coronavirus pandemic paralyzed most nonemergency medical practices this spring, the dialysis business, vital…
Fractyl nets $55M for intestine-resurfacing trial in type 2 diabetes
Hits, but mostly misses for Roche’s 4 late-stage trials of GI drug hopeful etrolizumab
FDA approves Guardant’s tumor-sequencing blood test as a Tagrisso lung cancer diagnostic
Heart-mapping Acutus Medical kicks off $158M Nasdaq IPO
Market Watch
more-
Gold futures suffer biggest daily dollar decline in more than 7 years
Rise in global stock markets, U.S. Treasury yields pressure gold and silver
Bio Business News
more
WCLC: Xcovery’s Xalkori challenger shines in phase 3 lung cancer showdown
Xcovery pitted its ALK inhibitor against Pfizer’s Xalkori—the first-ever FDA-approved…
Battered and bruised Seres Therapeutics see shares skyrocket on phase 3 win
Seres Therapeutics has endured a tough few years of trials…
AbbVie infectious disease exec jumps ship to COVID antiviral biotech
AbbVie and Roche alum Janet Hammond, M.D., Ph.D., Sc.M., F.C.P.…
World News
more
SpaceX Starlink wins permit to send internet to customers like you
SpaceX has been busy building its Starlink satellite constellation. To…
Facebook video calls soar 1000% during Italy’s lockdown
Facebook has seen usage across its platforms surge in countries…
WeWork board’s special committee is demanding that SoftBank follow through with investment
Five months after SoftBank agreed to a massive bailout of…
Business is booming for dialysis giant Fresenius. It took a $137M bailout anyway
Fractyl nets $55M for intestine-resurfacing trial in type 2 diabetes
Hits, but mostly misses for Roche’s 4 late-stage trials of GI drug hopeful etrolizumab
FDA approves Guardant’s tumor-sequencing blood test as a Tagrisso lung cancer diagnostic
WCLC: Xcovery’s Xalkori challenger shines in phase 3 lung cancer showdown
Battered and bruised Seres Therapeutics see shares skyrocket on phase 3 win
AbbVie infectious disease exec jumps ship to COVID antiviral biotech
Dyne Therapeutics grabs $115M to ramp up muscle disease pipeline
Gold futures suffer biggest daily dollar decline in more than 7 years
Oil futures end lower, but expectations for tighter U.S. supplies limit losses